Related references
Note: Only part of the references are listed.The clinical significance of DJ-1 and HE4 in patients with endometrial cancer
Marco Benati et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2018)
Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer
Jisup Kim et al.
GYNECOLOGIC ONCOLOGY (2018)
Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings
Rui-Lan Huang et al.
CLINICAL CANCER RESEARCH (2017)
Clinical Use of Programmed Cell Death-1 and Its Ligand Expression as Discriminatory and Predictive Markers in Ovarian Cancer
Jayanta Chatterjee et al.
CLINICAL CANCER RESEARCH (2017)
Epigenetic changes as prognostic predictors in endometrial carcinomas
Sanja A. Farkas et al.
EPIGENETICS (2017)
Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial
Britton Trabert et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer
Jing Bian et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2017)
Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer
Laura Devis et al.
JOURNAL OF PATHOLOGY (2017)
Next-Generation Sequencing in Gynaecological Tumours: The Prognostic and Predictive Value of the Most Common Mutations Found in Ovarian, Endometrial, and Cervical Tumours: Literature Review and the University Medical Centre Utrecht Next-Generation Sequencing Data
Eline van Winkel et al.
PATHOBIOLOGY (2017)
DJ-1 is a reliable serum biomarker for discriminating high-risk endometrial cancer
Annalisa Di Cello et al.
TUMOR BIOLOGY (2017)
Circulating Tumor DNA as Biomarkers for Cancer Detection
Xiao Han et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2017)
A phase II trial of durvalumab (Medi 4736) in advanced endometrial cancer: PHAEDRA.
Yoland Catherine Antill et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients
Ingvild L. Tangen et al.
BRITISH JOURNAL OF CANCER (2017)
miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer
Zhonghui He et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Confirmation of ProMisE: A Simple, Genomics-Based Clinical Classifier for Endometrial Cancer
Aline Talhouk et al.
CANCER (2017)
Endometrial Carcinoma Role of Current and Emerging Biomarkers in Resolving Persistent Clinical Dilemmas
Tatiana N. Buhtoiarova et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program
Roberto Angioli et al.
TUMOR BIOLOGY (2016)
L1CAM as a prognostic marker in stage I endometrial cancer: a validation study
Elisabeth Smogeli et al.
BMC CANCER (2016)
L1CAM expression in endometrial carcinomas: an ENITEC collaboration study
Louis J. M. van der Putten et al.
BRITISH JOURNAL OF CANCER (2016)
Immunotherapy in Endometrial Cancer: In the Nick of Time
Josep Maria Piulats et al.
CLINICAL CANCER RESEARCH (2016)
Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer
Floor J. Backes et al.
GYNECOLOGIC ONCOLOGY (2016)
Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer
Pinar Kemik et al.
GYNECOLOGIC ONCOLOGY (2016)
CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas
Monica Pascual-Garcia et al.
HUMAN PATHOLOGY (2016)
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer
Inge C. Van Gool et al.
MODERN PATHOLOGY (2016)
Prognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer
Milosz Wilczynski et al.
PLOS ONE (2016)
Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance
Donal J. Brennan et al.
BMC CANCER (2015)
Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy
Yuji Ikeda et al.
BRITISH JOURNAL OF CANCER (2015)
Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study
Ludek Zavesky et al.
PATHOLOGY & ONCOLOGY RESEARCH (2015)
Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study
Stella Capriglione et al.
TUMOR BIOLOGY (2015)
Prognostic role of hormone receptors in endometrial cancer: a systematic review and meta-analysis
Yanli Zhang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2015)
MicroRNA expression in human endometrial adenocarcinoma
Sanja Jurcevic et al.
CANCER CELL INTERNATIONAL (2014)
Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy
Anke Vanderstraeten et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results
T. Bosse et al.
EUROPEAN JOURNAL OF CANCER (2014)
Discovery and validation of methylation markers for endometrial cancer
Nicolas Wentzensen et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
D. Rossille et al.
LEUKEMIA (2014)
A critical review on HE4 performance in endometrial cancer: where are we now?
Roberto Angioli et al.
TUMOR BIOLOGY (2014)
Diagnostic value of serum HE4 in endometrial cancer: a meta-analysis
Yachun Bie et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2014)
ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomas
Henrica M. J. Werner et al.
MODERN PATHOLOGY (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients
Beyhan Omer et al.
TUMOR BIOLOGY (2013)
pHH3 and survivin are co-expressed in high-risk endometrial cancer and are prognostic relevant
A. Brunner et al.
BRITISH JOURNAL OF CANCER (2012)
Molecular Pathways: Next-Generation Immunotherapy-Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
Daniel S. Chen et al.
CLINICAL CANCER RESEARCH (2012)
Predicting the Coexistence of an Endometrial Adenocarcinoma in the Presence of Atypical Complex Hyperplasia Immunohistochemical Analysis of Endometrial Samples
Elisabeth J. M. Robbe et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
New insights in endometrial carcinogenesis
Giuseppina D'Andrilli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
E. Bignotti et al.
BRITISH JOURNAL OF CANCER (2011)
Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort
Ian Jacobs et al.
LANCET ONCOLOGY (2011)
Tryptase-positive mast cells and CD8-positive T cells in human endometrial cancer
Domenico Ribatti et al.
PATHOLOGY INTERNATIONAL (2011)
Clinical Significance of Regulatory T Cells and CD8+ Effector Populations in Patients With Human Endometrial Carcinoma
Wen Chun Chang et al.
CANCER (2010)
Inflammatory events in endometrial adenocarcinoma
Alison E. Wallace et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Clinical Significance of Serum DKK-1 in Patients With Gynecological Cancer
Tao Jiang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures
Melih C. Boruban et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2008)
PTEN: a new guardian of the genome
Y. Yin et al.
ONCOGENE (2008)
The p53 tumor suppressor participates in multiple cell cycle checkpoints
Luciana E. Giono et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Endometrial cancer in women 45 years of age or younger: A clinicopathological analysis
GP Pellerin et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Share Paper
